Neopterin is produced and secreted in large amounts by interferon-g stimulated human monocytes/ macrophages. Neopterin measurement in urine and semm provides a usefi.ll possibility to estimate the dcgree of ccllular (Thl-type) immune activation, which is directed against viral infections, intracellular bacteria, and certain parasites. Also in malignancy, autoimmw1e diseases and allograft rejection episodes neopterin sensitively reflects the extent of cellular immune activation. Determination of neoptcrin concentrations can be conveniently performed by immunoassay like ELISA or RIA, and HPLC. The major diagnostic applications of neopterin monitoring are: surveillancc of the immw1e status of organ recipients, therapy control and prognosis of diseasc progression in tumor diseascs and HIV infections and also detection of unknown infections in e.g. blood banks. High neopterin levels are strongly associated with oxidative stress, opening an additional application field of ncopterin monitoring to estimate the extent of tissue damagc in the course of immune activation.
Introduction
Neopterin, 2-amino-4-o:x0-6-( D-ervthro-l , 2, 3-trihydrm",)'propyl)-ptcridine ( Fig. I ) and its reduced form, 7,8-dihydroneopterin are produced and secretcd in large quantities by human monoc\'tcs/ macro phages upon stimulation ,,"ith intett"cron (IFN)-y, as has been shown in cell culture e:xperiments (1 ) . The biochemical source of these pterin derivatives is guanosine triphosphate (GTP ). GTP cyclnhydrolase I is tl1e key enzyme for the com"ersinn of GTP to 7,8-dihydroneopterin triphosphate which is the precursor fc)[ most pteridin compounds including folate, methanopterin, tetrah ydrobiopterin ~Allthor to whom correspondence should be addressed. Dedicated to the 70th birthdav of Prof. Helmut Wachter, Innsbruck, Austria (BH4) and neopterin. BH 4 , an important co-factor for various enzymes recruiting molecular oxygen as oxidant, is formed involving the enzymes 6-pyruvoyltetrahydropterin synthase (PTPS) and sepiapterin reductase. In human monocytes/macrophages the activity of PTPS is low. Accumulating 7,8-dihydroneopterin triphosphate is partly oxydized and converted to neopterin and 7,8-dihydroneopterin by phosphatase;. Significant neopterin production is restricted to hum,ms and primates. Thereby, mainly monocytic cells are the putative source of neopterin concentrations in body fluids. Recent data suggests that dentritic cells are probably the most relevant source of neopterin production during the cell mediated immune response in vivo (2) . In monocytes ' macrophages and in the myelomonocytic cell linc THP-l , IFN-y was found to be the only c\'tokinc to directly stimulate neopterin production (3 ). TUJl1()1" necrosis factor-a (TNF-a) and bacteriallipopolysaccharides are co-stimuli for neopterin production (4). Since IFN-y is largely produced by Thl-type lymphocytes, stimuli activating this cell population interfere indirectly with the production of neopterin. Cytokines like IL-12 superinduce IFN -y-mediated neopterin production, whereas the Th2-type cytokines IL-4 and IL-IO decrease neopterin production in peripheral blood mononuclear cells and THP-l cells (5) . Likewise, immunosuppressing agents like dexamethasone reduce IFN -y and neopterin production in peripheral blood monocytic cells (4, 6) . In this sense, neopterin concentrations reflect the effect of a cascade of several cytokines on monocyte/ macrophage population.
These conditions of neopterin enable its use in clinical laboratories to monitor the state of immune activation, because high neopterin concentrations are found in situations when the cellular (Th-l type) immune system is activated (7) . Furthermore, a close correlation was established between neopterin concentrations in serum or urine and the extent of immunological response against, e.g. viral challenge or malignancy (8) .
Neopterin as indicator of oxidative stress
The immune system employs small and highly reactive species, e.g., hypochlorite, hydroxy radical, superoxide anion, or peroxynitrite, as an effective mechanism to destroy cell structures recognized as 'non-self' which may develop during malignant progress, infections or autoimmune reactions. Therefore, immune stimulation is associated with high amounts of reactive species produced by immunocompetent cells, and a broad arsenal of antioxidati,"e defense mechanisms is employed to control overwhelming generation of reactive oxidants and to guarantee cell homeostasis (9) . Increased oxidative metabolism as a recnlitment of immunocompetent cells against viral and bacterial challenge may result in oxidative stress ( 10) , and neopterin is closely associated with immune induced cytotoxicity Therefore neopterin reflecting the degree of immune activation can serve indirectly as an indicator of oxiPteridines / Vol. 10 / No.3 dative stress (11). This relation is supported by several studies revealing associations between oxidative tissue damage in certain diseases and high neopterin concentrations (Table 3) . Recent findings revealed increased neopterin concentrations in patients with, e.g. dementia. In parallel, low antioxidant status indicated by decreased a-tocopherol concentrations seems to be associated with oxidative stress in these patients, which points to the possible implication of the immune system in neurodegenerative disorders (12). Besides, increase of neopterin concentration may represent an unfavourable sign fc)r tissue damage as a consequence of oxidative stress, the more that neopterin is likely involved by itself to enhance the effects of oxidative stress (13).
Methodology of neopterin determination
In serum, cerebrospinal fluid, and other proteincontaining body fluids, neopterin can conveniently be measured by ELISA or RIA (14,15). In most of commercially available ELISAs, polyclonal antibodies are applied. Depending on the sensitivity of the test kit, 20-100 )..1.1 of specimen is required for a single determination. The limit of detection limit lies around 2 nmoljl. For RIA, 1251-labelled neopterin is used. The performance is similar to precision and detection limit of the ELISA method.
N eopterin concentrations in samples remain stable for 3 days, therefore cooled shipping is not absolutely necessary. Anyway, to be on the safer side samples should be stored at 4-8°C in the dark. Samples to be stored up to 3 months must be kept frozen at -20°e. Repeated thawing an.d refreezing must be avoided. There is no difference in neopterin concentrations between plasma and senlm. Due to much higher concentrations of neopterin in bile fluid than in serum, such samples should be prediluted with physiological sodium chloride solution. Measurement by immunoassays is also possible in saliva, gastric and pancreatic juice, synovial fluid as well as in cerebrospinal fluid (CSF). Normal concentrations of the latter were determined by 4.2± 1.0 nmoljl. Normal values of serum are listed in Table 1 .
Neopterin is a stable molecule and because of its low molecular mass, it is excreted via the kidneys. In urine neopterin can be determined by high perfc)rmance liquid chromatography (HPLC) (16) . Neopterin is preferably detected by its natural fluorescence (excitation: 353 nm, emission: 438 nm).For neopterin measurements in spot urine samples, neopterin is referred to creatinine concentrations which can be conveniently determined simulta- Renal disturbations hardly int1uence the neopterin per creatinine ratio. However, in uremic patients, extremely high serum neopterin concentrations up to 200 nmol/l are fow1d (17).
Lahoratory dignostic application of neopterin measurement
The diagnostic value of neopterin measurement is based on the close correlation between the degree of cellular immune activation and neopterin excretion. \Vhile specific information of neopterin concentration is less important for assessing diagnosis, the amount of neopterin and its follow-up can provide information about progress and seriousness of the disease and, moreover, allow estimation on SU[yi\"(ll in certain tumor diseases and HIV-infection .
.Veopterin in viral infections
During viral infections, an elevation of the neopterin concentration can be observed in nearly all patients. This is particularly true fIX hepatitis A, B (18) and C (19,20 ), Epstein-Barr-virus infections and cytomegalovirus infections (21,22). Increased neopterin concentrations are also evolved during most other \'iral di seases, including measles (23 ), mumps, chickenpox (2 -! ), rubella (25 ) and influenza ( 26 J. Generalh~ in acute \-iral infections, neopterin concentrations increase during the incubation period before symptoms of infections appear and before production of specific antibodies becomes detectable (24) (Fig. 2) . Highest neopterin concentrations are observed just before the seroconversion phase, and neopterin concentrations subsequently drop to normal values in parallel to the progressive increase of antibody titers. Therefore, neopterin measurement can be applied to control the progress of infection and to estimate the state of cellular immune response. In HIV infection the course of neopterin concentration differcs from other infections in as much as neopterin concentrations will not reach normal values after infection (Fig. 2) . Neopterin concentrations during acute infections could be confirmed in experimental infections in animal models (e.g. SIV in rhesus macaques (27) and yellow fewer (28 » and also during vaccination with live vaccines, e.g. measles and mumps. In the latter case, the t()llow-up of neopterin concentrations resembles viral infections even in the absence of clinical symptoms (25,29,30).
Neopterin in HIV infections
In nearly all HIV-infected patients, neopterin concentrations raise within weeks in the acute phase .... after infection before seroconversion (8, 31, 32) . In the following asymptomatic phase, neopterin concentrations decrease in parallel to low virus titer (33 ), but neopterin concentrations usually do not normalize. In contrast, chronically elevated neopterin concentrations compared to normal values are still present in 80% of w1treated HIV-infectcd individuals (34,35) . With disease progression (36-38), neopterin concentrations will raise again and will reach highest values when full blown AlDS develops (39) , paralleled by decreasing CD4+ T-Iymphocyte counts (40,41 ) . Neopterin was established as a potent predictive marker of AIDS progression even in early states of HIV-intection, and it provides at least a similar prognostic value for disease progression as other predictive parameters (42-45 ) like CD4+ T-cell subset counts (34,41 ,46) or quantitative PCR for HIV-mRNA (47) . Neopterin concentrations also correlate to viral load (39, 47) . Antiretroviral therapy is reflected in a decrease of neo pterin concentrations (48) (49) (50) . Likewise, in HIV-infected individuals there is a close association between high neopterin concentrations in the cerebrospinal fluid (CSF) and the occurrence of neuropsychiatric abnormalities (51, 52) . In the course ofHIVinfection, CSF neopterin concentrations can even reach higher values than serum concentrations (53) .
Inlections with parasites and bacteria
High neopterin concentrations were found in acute malaria (54) (55) (56) , and an association between duration of parasitic load and neopterin con centraPttTidines / Vol. 10 / No.3 tions was demostrated (57) . After beginning of therap)~ serwn concentrations will rapidly decrease to normal values within several days (58 ) . In human Schistosoma infection, increased serum neopterin concentrations are found particularly in individuals with hepatosplenic involvement and less pronOlmced in manifestations with intestinal involvement (59) .
In patients with lung tuberculosis, high neopterin concentrations correlate with disease extent and activity (60) . The application of neopterin measurement in therapy control has been proofed (61 ) to correlate with the extent of immune response, and also in tuberculosis with HIV coinfection neopterin provides useful information (62). In patients with tuberculoid/ borderline leprosy and in lepromatous leprosy (63) , 75% of patients had elevated urinary neopterin concentrations. Melioidosis, particularly septic melioidosis, was associated with high concentrations of neopterin, and the predictive value of neopterin for survival was substantiated (64) . In bacterial infections, neopterin concentrations are usually low, but will increase in protracted bacterial infections (65) . Neopterin measurement provides a sound method for differential diagnosis between acute bacterial and viral infections and was reported in patients with pneumonia to discriminate better between viral and bacterial infection than blood sedimentation rate or leucocyte count (65) . A distinct situation is manifested in Lyme neuroborreliosis: High neopterin concentrations are found in CSF of patients, whereas serum neopterin was not markedly increased (66) . These data confirms intrathecal neopterin production in Lyme neuroborreliosis . In ,1Il analogous manner, acute viral and bacterial encephalitis elicits high CSF neopterin concentrations (67) whereas serum levels are not increased in the absence of systemic infections. This difference G1l1 help to discriminate between cerebral infections , 1Ild other acute febrile manifestations (68 ) .
S ecpterin in autoimmune diseases
In autoimnllule diseases neopterin measurelnent supports the estimation of disease activity, providing information for early therapeutical treatments and serves as a differential-diagnostic criterion. In rheumatoid arthritis, high neopterin concentrations are found in blood or urine, following the course of disease. Highest levels are seen in the synovial f1uid during relapse (69, 70) . Neopterin measurement can be applied as an additional criterion to discriminate rheumatoid arthritis from osteoarthritis, because in the latter case, neopterin concentrations are usually within the normal range (69) . In patients with systemic lupus erythematosus (SLE), extremdy high neopterin concentrations are found in the active state of the disease (71, 72 ) . The correlation between serum neopterin concentrations and disease acti\'in' was demonstrated in a ll1ultiyariate ,1l1,1Ini<' . COl1-tlrming neopterin as the most represcnutl\·c immune activation marker in SLE in addition w serum soluble tumor necrosis factor receptor. soluble interlcukin-2 receptor, or soluble CD8 (73 l . Other autoimmune diseases were studied " 'ith respect to increased neopterin concentrations including Wegeners granulomatosis (74), dermatomyosistis (75), inflammatory bowel diseases, e.g., Morbus Crohn (76 ), ulcerative colitis (77), and celiac disease (78), or sarcoidosis (79) . Again, these diseases are associated with increased neopterin concentrations in urine and serum particularly in the active states of the diseases. In lung sarcoidosis, especially bronchoalveolar lavage f1uid has high concentrations of neopterin, correlating well with elevated lymphocyte counts (80) 
. (For details see also Nassonov et al., this issue).

Neopterin in cardiovascular diseases
Patients with dilated cardiomyopathy, chronic myocarditis (81 ) and children with Kawasaki syndrome, implicating coronary artery dilatation (82), present with increased neopterin concentrations. In patients with myocarditis, n eopterin levels correlate highly significantly witll tlle course of disease, whereas stabilisation of tlle disease leads to a considerable decrease of neopterin conce ntrations unto the normal range. In patients with acute rheumatic fever (83) , the frequency of increased neopterin concentrations was found >80%. Still higher neopterin levels were found in patients developing a combined aortic and mitral insufficiency. Neopterin may allow easy assessment of the severity of cardiac involvement in acute rheumatic fever. Neopterin concentrations also show a significant decrease during treatment. However after myocardial infarction, transiently high neopterin levels are predominantly observed in patients (84) . (For details see also N assonov et ai., this issue).
Neopterin concentrations in malignant diseases
The sensitivity of neopterin measurement in tun10r patients depends on the localization of the malignant process (Table 2 ) , (8 5) . The frequency of elevated neopterin concentrations in serum ranges from 20% in breast cancer or malignant melanoma to almost 100% in hematological neoplasias (Table  2 ). In addition, also tun10r mass, infiltration stage and -more generally -tumor progression inf1uence the extent of neopterin production (86) . Therefore, neopterin measurement in twnor patients are not impon,1I1t tor diagnosis but for estimation of prognO'l' .111d thcr~lpY control (87) (88) (89) (90) . From several , md ic-; it ~c,lmc e\'ident that neopterin concentratiun, -' : .111 'lTye ,1' , 111 indcpendent predicti\'e paralTIe ter tor th c uUt-.:< Hl1C ( ) f lluliglunt grO\\"th \\'ith respect to ,honcncd ,ur-·i\.ll \\'hC11 11coprcrin L011-centrations are high. Thi~ ,1s<.(xi.ltion \\ ',1'-Sh()\\"]l. e.g. in hematological neo plasi.1S 191. in L.lrcinol1u of the uterine cen 'ix (87 ) or of the m 'aries , 88 1. i11 colon carcinoma (92 ) , lung cancer (93 ), prostate cancer (89 ), hepatocellular cancer (90) and squamous cell carcinoma of the oral cavity (94). rurthermore, neopterin monitoring in the post-therapeutical phase can help to detect tumor relapse ealicr and may provide an indication fcx adjuvant therapeutical measures (88) .
Neopterin in organ transplantation
Follow up of solid allograft recipients (kidneys, liver, pancreas, heart) b y neopterin measurement has become a powerful tool in surveillance after transplantation surgery (95) (96) (97) (98) . Neopterin measurement in morning urine or senlm/plasma allows to early detect inmmnological complications regarding organ rejection or v iral infections. In uncomplicated courses the neopterin level will decrease to normal values after surgery; whereas sustaining high concentrations indicate velY early a threatening complica- tion. The reason for neopterin elevation must be differential-diagnostically clarified to discriminate between organ rejection and infections (99) . However, neopterin measurement was also suggested tc)r differential diagnosis of rejection and infection in transplantation surgery (100) . In liver transplantation, parallel measurement of neopterin in serum and bile allows discrimination between ongoing rejection and viral infection (101 ) . Also in pancreas transplantation, measurement of neopterin in the pancreas juice in parallel to serum or urine provides additional information about the origin of immune activation (102) . In general, studies have shown that neopterin is a properly predictive marker for long-term graft survival (98) .
In bone marrow transplantation, neopterin measurement allows to monitor the course of inunune system destruction and reconstitution, reaching a new homeostasis . Furthermore, also in this case neopterin monitoring is helpful in diagnosing Pteridines / Vol. 10 / ~o. 3 immunological complications as to be graft-versushost reactions or infections (l 03).
Neopterin in blood transfusion
In spite of considerable progress in the last years in serologic and modern molecular biology technigues supporting blood donor screening, e.g., PeR-analysis, certain residual infectious risks still remain in blood transfusion. Potential hazardous pathogens may remain undetected either because they are known but not screened or they are unkown, so that usually performed screening technigues do not respond. In addition blood donation was collected within the diagnostic window of an infectious process, i.e. the period between infection and seroconversion, before antibody production is detectable. During the acute phase of infections, neopterin concentrations generally reach particularly high values (Fig. 2 ) . Enhanced neopterin excretion IS not specific for one infectious disease but responds to a broad variety of known and hitherto not-characterized pathogens. Thus, applying neoprerin measurements for blood donor screening can exclude virus infections during the acute phase when \ irus load is highest and it allows to further shorten the diagnostic window in addition to normally .lpplied screening methods (31, 104) . N eopterin ~creening of blood donations became compulsory in .\ustria since 1994. In this way, subclinical infections or silent systemic disorders are sensitively detected b~' increased neopterin concentrations, and suspicious blood units are discarded to increase the security of transfusion (105, 106) . It was shown that in blood donors with increased neopterin concentrations ( > 10 nmoljl), acute cytomegalovinls infections \\"hich have been unrecognized dm'ing anamnesis were 17-times more frequent than in such infected individuals with normal neopterin concentrations ( 106) . Similarly, the incidence of acute Epstein-Barr \'irus and parvovirus B19 infections was accompanied with a 4-6 times higher frequency in individuals with increased neopterin concentrations (107) . ,-\1so in chronic and clinically inconspicuous hepatitis C infection, increased neopterin concentrations were 7 times morc frequent (108) .
Conclusion
Neopterin is a sensitive marker to estimate cellular immune activation. High neopterin concentrations in body fluids especially in urine and serum can be fcmnd in viral infections including HIV and in infections with intracellular parasites and bacteria, in malignant diseases, autoinunune diseases and during allograft rejection episodes. The diagnostic importance of neopterin measurement is evident by the possibility to estimate the extent of cellular immune activation. Applications of laboratory neopterin measurements are for example: therapy control in HIV or malignant diaseases, survival prognosis,surveillance of allograft recipients, and screening fc)r infectious pathogens in blood transfusion. Measurement of neopterin is easier to perform than other methods to determine immune activation states as to be, e.g. cell countings. In contrast to the determination of cytokines, determination of neopterin represents the net reaction of the cellular immune system on a pand of different immune mediators < U1d hence monitors the final outcome of various pathways to dicit an immune response irrespective of the responsiveness of irnmunocompetent ce lls. Neopterin as an analyte is stable and its measurement fullfills the criteria of quality control in clinical chemical laboratory analysis. In various applications, determination of neopterin was proofed for routine analysis and its eloquent benefits in relation to the emerging costs render neopterin useful as a marker of immune activation.
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